Sakk 17/18-Origin Trial: Efficacy And Safety From A Multicenter Phase Ii Trial Of Gemcitabine And Atezolizumab In Patients With Advanced Nsclc Progressing On Immune Checkpoint Inhibitors
Atezolizumab;Gemcitabine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Sakk 17/18-Origin Trial: Efficacy And Safety From A Multicenter Phase Ii Trial Of Gemcitabine And Atezolizumab In Patients With Advanced Nsclc Progressing On Immune Checkpoint Inhibitors ### Output: Atezolizumab;Gemcitabine